Stocks
›
Press Release
Advertise
USD
EN
App
Download App
Crypto
Stocks
Forex
Metals
Portfolio
Exchanges
Token Sales
News
Tools
Hotspot
Close
Home
Stocks
GNPX
News
Market Closed
GNPX
Genprex
$ 2.08
-5.88%
Last 24H
Trading with leverage comes with a high risk and may not be suitable for everyone.
Trading with leverage comes with a high risk and may not be suitable for everyone.
Watchlist
Portfolio
Updated 2 days ago
Overview
Price Prediction
Brokers
News
Dividend
Earnings
Genprex News
Latest Genprex Stock News & GNPX Headlines
Genprex to Highlight Dual Delivery Strategy for Diabetes Gene Therapy at Future of Cell and Gene Therapy Symposium
5 days
ago |
prnewswire.com
Genprex Presents Data Showing Reqorsa® Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Patients, Supporting TUSC2 as a Key Regulator of Resilience to Aging-Associated Stress
11 days
ago |
prnewswire.com
Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer
12 days
ago |
prnewswire.com
Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
19 days
ago |
prnewswire.com
Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging
a month
ago |
prnewswire.com
Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2 months
ago |
prnewswire.com
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy
3 months
ago |
prnewswire.com
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies
3 months
ago |
prnewswire.com
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer
5 months
ago |
prnewswire.com
Genprex to Participate at BIO International Convention 2026
5 months
ago |
prnewswire.com
Load More
Download App
Keep track of your holdings and explore over 40,000 cryptocurrencies
Market Closed
GNPX
Genprex
$ 2.08
-5.88%
Last 24H
Trading with leverage comes with a high risk and may not be suitable for everyone.
Trading with leverage comes with a high risk and may not be suitable for everyone.
Watchlist
Portfolio
Updated 2 days ago
People Also Watch
Top
Gainers
Losers
Symbol
Last Price
24H CNG
AAPL
$ 356.27
0.39%
NVDA
$ 162.85
-2.01%
MSFT
$ 523.88
0.17%
GOOG
$ 292.52
-0.96%
AMZN
$ 266.66
-0.29%
Explore our Tools
Watchlist
Portfolio
Alerts
Market Overview
Converter
ICO Calendar
Stocks
Never miss a story...
Subscribe to Newsletter